These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11774964)

  • 1. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy.
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Kinoshita H
    Br J Surg; 2002 Apr; 89(4):418-22. PubMed ID: 11952580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Does interferon-alpha prevent recurrence of malignant tumors in patients with hepatitis C - related liver cancer?
    Ann Intern Med; 2001 May; 134(10):S-7. PubMed ID: 11357861
    [No Abstract]   [Full Text] [Related]  

  • 4. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
    Vezali E; Aghemo A; Lampertico P; Colombo M
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):455-64. PubMed ID: 21435968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma.
    Qu LS; Jin F; Huang XW; Shen XZ
    J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatments for hepatitis virus C infections].
    Pol S; Fontaine H; Vallet-Pichard A
    Gastroenterol Clin Biol; 2001 Mar; 25(3):287-307. PubMed ID: 11395676
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
    J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postoperative interferon therapy after resection of hepatitis C virus-related hepatocellular carcinoma].
    Katagiri S; Tokushige K; Yamamoto M
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):795-801. PubMed ID: 18525184
    [No Abstract]   [Full Text] [Related]  

  • 11. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Clavien PA
    Ann Surg; 2007 Jun; 245(6):843-5. PubMed ID: 17522507
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.
    Chong CC; Lai PB
    Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Yamazaki O; Shiomi S; Tamori A; Oka H; Igawa S; Kuroki T; Kinoshita H
    Ann Intern Med; 2001 May; 134(10):963-7. PubMed ID: 11352697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
    Brechot C
    Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.